| Phase 4 |
| NCT06289673 |
Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute… |
Acute Lymphoblastic Leukemia |
Recruiting |
2026-07-14 |
| Phase 2/3 |
| NCT03117751 |
Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and… |
Acute Lymphoblastic Leukemia |
Active, Not Recruiting |
2026-06-17 |
| NCT01046825 |
Mature B-Cell Lymphoma And Leukemia Study III |
Mature B-Cell Lymphoma |
Active, Not Recruiting |
2026-06-02 |
| Phase 2 |
| NCT05955261 |
A Study of Venetoclax in Combination With Conventional Chemotherapy in Pediatric Patients… |
Acute Myeloid Leukemia |
Recruiting |
2026-09-17 |
| NCT04558736 |
Haploidentical HCT for Severe Aplastic Anemia |
Aplastic Anemia |
Recruiting |
2026-09-16 |
| NCT05535166 |
Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly… |
Medulloblastoma |
Recruiting |
2026-09-15 |
| NCT07428993 |
Evaluating Efficacy of B7-H3-CAR T Cells Administered at the End of Upfront Map… |
Pediatric Osteosarcoma |
Recruiting |
2026-09-01 |
| NCT06390319 |
Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed… |
T-cell Acute Lymphoblastic Leukemia |
Recruiting |
2026-08-10 |
| NCT07085338 |
A Phase II Study With a Safety Run-In of the Addition of N-803 to a Chemoimmunotherapy… |
Neuroblastoma Recurrent |
Recruiting |
2026-08-07 |
| NCT07616154 |
Haploidentical Donor Hematopoietic Cell Transplant for Sickle Cell Disease |
Sickle Cell Disease |
Recruiting |
2026-07-23 |
| NCT06533748 |
Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia… |
Acute Lymphoblastic Leukemia |
Recruiting |
2026-07-16 |
| NCT06023641 |
Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and… |
Rhabdomyosarcoma |
Recruiting |
2026-06-15 |
| NCT07228741 |
Resistance Exercise and Incretin Mimetic for Cardiometabolic Health in Survivors of ALL… |
Acute Lymphoblastic Leukemia |
Recruiting |
2026-06-04 |
| NCT06528691 |
Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With… |
High Grade Glioma |
Recruiting |
2026-05-13 |
| NCT05583721 |
Relationship Between Abnormal Myocardial Perfusion and Diastolic Dysfunction in Sickle… |
Sickle Cell Disease |
Recruiting |
2026-05-06 |
| NCT04968990 |
Treatment of Newly Diagnosed Patient's With Wilm's Tumor Requiring Abdominal Radiation… |
Wilms Tumor |
Recruiting |
2026-04-23 |
| NCT06847269 |
CAR T CELL Therapy for Pediatric, Adolescent and Young Adult Patients With CD19-Positive… |
Acute Lymphoblastic Leukemia |
Recruiting |
2026-03-25 |
| NCT05664126 |
Haplo-identical Viral-Specific T-cells for Treatment of Cytomegalovirus and Adenovirus… |
Cytomegalovirus |
Recruiting |
2026-02-23 |
| NCT04733534 |
An Open-Label Intervention Trial to Reduce Senescence and Improve Frailty in Adult… |
Frailty |
Active, Not Recruiting |
2026-09-30 |
| NCT07790913 |
Obesity Treatment With Phentermine-Topiramate ER in AYA Surviving Leukemia and Lymphoma |
Acute Lymphoblastic Leukemia in Remission |
Not Yet Recruiting |
2026-09-23 |
| NCT02792582 |
A Phase II Trial of Intensity-Modulated Proton Therapy for Incompletely Resected… |
Craniopharyngioma |
Active, Not Recruiting |
2026-09-22 |
| NCT03849651 |
TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use… |
Acute Lymphoblastic Leukemia (ALL) |
Active, Not Recruiting |
2026-09-15 |
| NCT02114229 |
Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors |
Malignant Rhabdoid Tumor |
Active, Not Recruiting |
2026-09-01 |
| NCT04362293 |
Reduced Intensity Transplantation for Severe Sickle Cell Disease |
Sickle Cell Disease |
Active, Not Recruiting |
2026-09-01 |
| NCT01419067 |
A Phase II Trial of Limited Surgery and Proton Therapy for Craniopharyngioma or… |
Craniopharyngioma |
Active, Not Recruiting |
2026-08-19 |